IELASI, LUCA
 Distribuzione geografica
Continente #
AS - Asia 1.227
NA - Nord America 918
EU - Europa 698
AF - Africa 84
SA - Sud America 61
OC - Oceania 2
Totale 2.990
Nazione #
US - Stati Uniti d'America 906
CN - Cina 427
SG - Singapore 367
IT - Italia 213
VN - Vietnam 164
DE - Germania 122
HK - Hong Kong 97
SE - Svezia 77
KR - Corea 63
GB - Regno Unito 60
IN - India 51
NL - Olanda 50
BR - Brasile 39
TG - Togo 38
IE - Irlanda 36
RU - Federazione Russa 27
FI - Finlandia 25
AT - Austria 15
FR - Francia 15
JP - Giappone 15
ID - Indonesia 14
SC - Seychelles 14
AR - Argentina 12
BG - Bulgaria 10
CA - Canada 9
ZA - Sudafrica 9
CI - Costa d'Avorio 8
NG - Nigeria 7
PK - Pakistan 7
HR - Croazia 6
UA - Ucraina 6
CH - Svizzera 5
LT - Lituania 5
MK - Macedonia 5
PL - Polonia 5
ES - Italia 4
TR - Turchia 4
BD - Bangladesh 3
BE - Belgio 3
EC - Ecuador 3
EE - Estonia 3
JO - Giordania 3
MA - Marocco 3
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
IR - Iran 2
MX - Messico 2
PE - Perù 2
PH - Filippine 2
TW - Taiwan 2
AO - Angola 1
BF - Burkina Faso 1
BO - Bolivia 1
EG - Egitto 1
HU - Ungheria 1
KZ - Kazakistan 1
MD - Moldavia 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
TV - Tuvalu 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.990
Città #
Singapore 256
Ashburn 179
Hefei 157
Hong Kong 97
Chandler 78
Santa Clara 70
Fairfield 66
Seoul 62
Bologna 61
Southend 50
Beijing 47
Ho Chi Minh City 47
Hanoi 43
Lomé 38
Boardman 37
Dublin 36
Princeton 28
Dallas 27
Munich 26
New York 25
Milan 23
Dong Ket 21
Wilmington 21
Houston 19
Woodbridge 19
Los Angeles 18
Helsinki 16
Rome 16
Bengaluru 14
Redondo Beach 14
Seattle 14
Tokyo 13
Ann Arbor 12
Cambridge 11
Frankfurt am Main 11
Falkenstein 10
Jakarta 10
Nuremberg 10
Sofia 10
Des Moines 9
Falls Church 9
Vienna 9
Abidjan 8
Berlin 8
Guangzhou 8
Amsterdam 7
Nanjing 7
Abeokuta 6
Buffalo 6
Haiphong 6
Washington 6
Bern 5
Chicago 5
Lahore 5
Skopje 5
Tongling 5
Turin 5
Turku 5
Westminster 5
Bremen 4
Brooklyn 4
Florence 4
Hải Dương 4
Johannesburg 4
Lappeenranta 4
Mountain View 4
Qingdao 4
Redwood City 4
Shanghai 4
Shenyang 4
Thái Nguyên 4
Toronto 4
Yubileyny 4
Amman 3
Brussels 3
Can Tho 3
Chennai 3
Dongguan 3
Flero 3
Forlì 3
Haikou 3
Hangzhou 3
London 3
Ninh Bình 3
Orem 3
Ottawa 3
Paris 3
Phoenix 3
Rio de Janeiro 3
San Diego 3
São Paulo 3
Taizhou 3
Tianjin 3
Verona 3
Vũng Tàu 3
Warsaw 3
Wuhan 3
Zhengzhou 3
Baku 2
Boydton 2
Totale 1.976
Nome #
Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders 165
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib 148
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 139
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients 138
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma 136
Natural history of hypovascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced mr imaging in cirrhotic patients during surveillance program 129
Treatment of combined hepatocellular and cholangiocarcinoma 126
Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib 125
Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art 122
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma 118
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) 118
TKIs in combination with immunotherapy for hepatocellular carcinoma 117
Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments 116
Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia 109
Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm? 107
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 106
Experience with regorafenib in the treatment of hepatocellular carcinoma 105
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 103
Lenvatinib mesylate to treat hepatocellular carcinoma 101
Hot topics in hepatocellular carcinoma 100
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery 97
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib 93
Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience 85
Donafenib in hepatocellular carcinoma 78
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy 74
A case of Leishmania infection with focal splanchnic involvement without systemic symptoms: a potential anti-inflammatory role for vitamin D 71
A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival 67
An update on atezolizumab for hepatocellular carcinoma 66
Outcome of hepatic resection for HCC in ideal and non-ideal candidates 22
Totale 3.081
Categoria #
all - tutte 9.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 10 5 6 16 7 7 37
2021/2022314 10 1 19 8 29 18 8 35 22 13 105 46
2022/2023358 26 54 13 39 40 27 32 19 61 5 9 33
2023/2024210 7 26 14 14 39 43 10 13 14 10 12 8
2024/2025948 36 65 73 75 106 34 111 37 29 64 76 242
2025/2026991 242 219 169 159 195 7 0 0 0 0 0 0
Totale 3.081